Table 1. VEGFA genotype and allele frequencies of the cases and controls and their association with risk of HCC.
Polymorphism | Genotype/allele | HCC (n = 476) | controls (n = 526) | Crude OR 95% CI | Pa value | Adjusted ORb 95% CI | Pc value |
---|---|---|---|---|---|---|---|
VEGF | CC | 359 (75.4)d | 370 (70.3) | 1.00 | 1.00 | ||
936 C/T | CT | 112 (23.5) | 140 (26.6) | 0.83 [0.62,1.10] | 0.188 | 0.84 [0.60,1.19] | 0.325 |
TT | 5 (1.1) | 16 (3.1) | 0.32 [0.12,0.89] | 0.021 | 0.54 [0.17,1.70] | 0.295 | |
Genotypes | CT and TT | 117 (24.6) | 156 (29.7) | 0.77 [0.58,1.02] | 0.071 | 0.81 [0.58,1.13] | 0.221 |
Alleles | T | 0.128 | 0.163 | ||||
VEGF | GG | 162 (34.0) | 200 (38.0) | 1.00 | 1.00 | ||
634G/C | GC | 232 (48.8) | 248 (47.2) | 1.16 [0.88,1.52] | 0.302 | 1.10 [0.79,1.53] | 0.583 |
CC | 82 (17.2) | 78 (14.8) | 1.30 [0.89,1.88] | 0.170 | 1.13 [0.73,1.75] | 0.590 | |
Genotypes | GC and CC | 314 (66.0) | 326 (62.0) | 1.19 [0.92,1.54] | 0.189 | 1.11 [0.81,1.51] | 0.516 |
Alleles | C | 0.416 | 0.384 | ||||
VEGF | GG | 254 (53.4) | 296 (56.3) | 1.00 | 1.00 | ||
1612G/A | GA | 188 (39.5) | 198 (37.6) | 1.11 [0.85,1.44] | 0.447 | 1.22 [0.90,1.67] | 0.203 |
AA | 34 (7.1) | 32 (6.1) | 1.24 [0.74,2.06] | 0.412 | 1.16 [0.64,2.11] | 0.628 | |
Genotypes | GA and AA | 222 (46.6) | 230 (43.7) | 1.13 [0.88,1.44] | 0.355 | 1.21 [0.90,1.63] | 0.209 |
Alleles | A | 0.269 | 0.249 | ||||
VEGF | CC | 301 (63.2) | 290 (55.1) | 1.00 | 1.00 | ||
2578C/A | CA | 157 (33.0) | 202 (38.4) | 0.75 [0.58,0.98] | 0.031 | 0.72 [0.53,0.98] | 0.041 |
AA | 18 (3.8) | 34 (6.5) | 0.51 [0.28,0.92] | 0.024 | 0.48 [0.24,0.96] | 0.038 | |
Genotypes | CA and AA | 175 (36.8) | 236 (44.9) | 0.71 [0.55,0.92] | 0.009 | 0.69 [0.51,0.93] | 0.014 |
Alleles | A | 0.203 | 0.257 |
P value for crude odds ratio (OR) and 95% confidence interval (CI).
Adjusted for age, gender, HBV carrier state, family history of cancer, smoking, and drinking status.
P value for adjusted odds ratio (OR) and 95% confidence interval (CI).
Values in parentheses indicate percentages.